That is an extreme claim (in the sense of surprising, remarkable, unusual, and one that needs a lot more support than ordinary claims).

It is inadequately defended here. The argument that it violates fair exchange is tautological.

The workflows we have are not quite right for it. Coding has always been 10% coding and 90% debugging but I think the rate at which we generate the 10% will grow exponentially.

This means that the debugging has to grow. We will generate errors at an unprecedented rate.

LLMs trained on previous errors and methods won’t catch them. They’ll be more complicated and spread out over the code.

We need new tools to visualize the code and track errors. I think what it means to be a programmer will change. More testing, thinking and less klocs.

Perhaps it could be better, but a lot of people would pay a lot for a single good job offer. And you accepted it.

Example: the 4o or Claude are great for coding, summarizing and rewriting emails. So which domains require a slightly better model?

I suppose if the error rate in code or summary goes down even 10%, it might be worth $180/month.

Anyway, one other insight I would add is that the issues tend to come up at the interface between the systems. Your automation has to get some input and send some output and both those are pain points. That’s why we sometimes prefer imperfect monolith software.

1. find a good text book in the field as narrowly construed as possible, and just browse the table of contents.

This will give you a quick map of the field, and a place to put all the info you gain.

2. Read the management discussion in the 10k of a public version of the company you work at and 2 leading customers, and the transcript from the earnings call.

Fastest way to get up to date on challenges.

“BNT211 continues to show encouraging antitumor activity in patients with CLDN6-positive relapsed or refractory advanced solid tumors” <- interesting because they finally demo some effect in solid tumors in humans

“Follow-up of efficacy data at 1x108 CAR-T cells with or without CARVac shows an overall response rate (“ORR”) of 59% and a disease control rate (“DCR”) of 95%, with the CARVac cohort demonstrating a prolonged persistence of CAR-T cells” <- interesting because those are high response rate. Let’s hope it lasts and they can increase those rates but as a patient, you would take this.

Take a note from the pet shop boys: they never argue.

They also never calculate the currency they spend.

Solo dev vs 50 devs might need different tools just to get out of each others way.

I am sure that is less secure than a local only copy but this may be least bad of all alternatives.

You might even give a trusted person a login and have it on their phone so you can use theirs in an emergency.

You were very active with this friend for n years and it dropped off. Drop them a line.

Also, want it to be 100% local and privacy first.

Go to any business school site and just look at the MBA curriculum:

https://www.hbs.edu/mba/academic-experience/curriculum/Pages...

I would then focus on the introductory courses (typically Accounting, Valuation, Marketing, Org theory etc).

Find the syllabus for those courses or the text book and just browse it.

That won’t teach it all but it will sort of give you a map of the territory so you can look it up when you need to. About the level of memory most MBA grads have 5 years after graduation.

Secondly, if they removed all visible signs, that is great and very hopeful.

If my loved one had a serious medical condition, and there wasn’t a known cure — for instance if it comes back — I would look at the government database that lists current trials in the U.S. (assuming you live in the U.S) and then I would research each potential treatment in turn.